-
Mashup Score: 12
GRECCO-19: Is the use of colchicine among patients hospitalized with symptomatic COVID-19 associated with clinical benefit?
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 6REBEL Cast Ep81: COVID-19, Thrombosis, and Anticoagulation - REBEL EM - Emergency Medicine Blog - 4 year(s) ago
In this episode of REBEL Cast I sit down with Andrew Chernaik, MD to talk about the dilemmas involving COVID-19, thrombosis, and anticoagulation.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 4GRECCO-19 - 4 year(s) ago
In patients hospitalised with symptomatic coronavirus disease 2019, does the administration of colchicine improve clinical & laboratory outcomes?
Source: www.thebottomline.org.ukCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 3Dexamethasone for COVID: The RECOVERY trial - First10EM - 4 year(s) ago
Dexamethasone for COVID – our first treatment with an apparent mortality benefit. This is a critical appraisal of the RECOVERY trial.
Source: First10EMCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5Remdesivir: The ACTT-1 Trial - First10EM - 4 year(s) ago
Should we use remdesivir for COVID-19. A critical appraisal of the ACTT-1 trial, a double-blind RCT comparing remdesivir to placebo.
Source: First10EMCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 8
There continues to be a slew of publications coming out on a near daily basis in regard to COVID-19. Some publications will deserve their own…
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 5Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. - PubMed - NCBI - 4 year(s) ago
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Source: www.ncbi.nlm.nih.govCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 10
COVID-19 NIV: Helmet NIV may have several advantages over face masks including better tolerability and less air leaks. There is a dearth of evidence comparing these to NIV modalities.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 5
COVID-19 NIV: Helmet NIV may have several advantages over face masks including better tolerability and less air leaks. There is a dearth of evidence comparing these to NIV modalities.
Categories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 41
Remdesivir is being promoted as an anti-viral agent for the treatment of COVID-19. The first randomized, blinded, placebo-controlled trial of
Source: EMCrit ProjectCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @srrezaie: 1st Placebo-Controlled RCT on Remdesivir for #COVID19 via @PulmCrit https://t.co/YoXVHKQhaU #COVID19FOAM #FOAMed "Remdesivir…
-
RT @srrezaie: GRECCO-19: Colchicine for COVID-19? Not quite ready for primetime https://t.co/Xh26JMRuJF #FOAMed #COVID19FOAM https://t.c…